INMB

NASDAQ · Biotechnology

Inmune Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.51

+0.09 (+6.34%)

As of Feb 8, 2:20 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 80%

Hold 2 20%

Sell 0 0%

Price Target

Analyst Price Target +1,017.2% upside

Low Target $11.09

Average Target $16.87

High Target $25.84

Current Price $1.51

Current
$1.51

Target
$16.87

$11.09 $16.87 avg $25.84

Scenario Analysis

Bear Case

$11.09

634.4%

Low target

Base Case

$16.87

+1,017.2%

Avg target

Bull Case

$25.84

+1,611.3%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$20.51

-92.6% from high

52-Week Low

$7.92

+-80.9% from low

Target vs 52W High

$16.87

-17.7% vs high

Next Earnings Report

Feb 26, 2026 · After Market Close

10d

until earnings

EPS Est: $-0.25

Earnings in 10 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%